SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040493
Filing Date
2023-11-13
Accepted
2023-11-13 16:06:53
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1225925
2 ex31-1.htm EX-31.1 9393
3 ex31-2.htm EX-31.2 11497
4 ex32-1.htm EX-32.1 10082
  Complete submission text file 0001493152-23-040493.txt   6217550

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE envb-20230930.xsd EX-101.SCH 54442
6 XBRL CALCULATION FILE envb-20230930_cal.xml EX-101.CAL 56517
7 XBRL DEFINITION FILE envb-20230930_def.xml EX-101.DEF 208911
8 XBRL LABEL FILE envb-20230930_lab.xml EX-101.LAB 424732
9 XBRL PRESENTATION FILE envb-20230930_pre.xml EX-101.PRE 318855
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1008650
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 231398671
SIC: 2834 Pharmaceutical Preparations